{"id":624814,"title":"Post-Authorization Requirements - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T05:41:01.228000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/post-authorization-requirements.html","snippet":"Post-Authorization Requirements Once an application has received regulatory authorization, the sponsor is required to inform Health Canada of the following: Clinical Trial Site Information If clinical trial site information was not available at the time of application, a…","rawSnapshotUrl":"/api/snapshots/raw/624814","browseUrl":"https://replay.healtharchive.ca/job-6/20260227054101/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/post-authorization-requirements.html#ha_snapshot=624814","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}